Indications and uses
For irrigating the eye to help relieve irritation, discomfort and burning by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
For irrigating the eye to help relieve irritation, discomfort and burning by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
Drug Facts
NDC 0065-0530-01
| Active Ingredient | Purpose |
| Purified Water 98.6% | Eye Irrigation |
Benzalkonium Chloride 0.013% as preservative, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Acetate Trihydrate, Sodium Chloride, Sodium Citrate Dihydrate, Sodium Hydroxide and/or Hydrochloric Acid to adjust pH. The pH range of solution is in the physiologic range.
For irrigating the eye to help relieve irritation, discomfort and burning by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
For external use only
Obtain immediate medical treatment for all open wounds in or near the eyes.
This product is not to be used as a saline solution for rinsing and soaking soft contact lenses.
NOT FOR INJECTION OR INTRAOCULAR SURGERY.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
Store at 8o – 27oC (46o – 80oF)
In the U.S.,
Call 1-800-757-9195
Drug Facts
NDC 0065-0530-04
| Active Ingredients | Purpose |
| Purified Water 98.6% | Eye Irrigation |
For irrigating the eye to help relieve irritation, discomfort and burning by removing loose foreign material, air pollutants, (smog or pollen), or chlorinated water.
For external use only
Obtain immediate medical treatment for all open wounds in or near the eyes.
This product is not to be used as a saline solution for rinsing and soaking soft contact lenses.
NOT FOR INJECTION OR INTRAOCULAR SURGERY.
If swallowed, get medical help or contact a Poison Control Center right away.
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
Store at 8°-27°C (46°-80° F)
Benzalkonium Chloride 0.013% as a preservative, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Acetate Trihydrate, Sodium Citrate Dihydrate, Sodium Chloride and Sodium Hydroxide and/or Hydrochloric Acid to adjust pH. The pH of the solution is in the physiological range.
In the U.S., Call 1-800-757-9195
MedInfo@AlconLabs.com
NDC 0065-0530-01
eye
stream®
eye wash
solution
sterile
Alcon
1 FL OZ (30 mL)
EYE-STREAM®
eye wash
solution is a sterile and stable
solution that is specially
designed and packaged for use
in the eye(s). Formulated as a
buffered salt solution, it closely
approximates normal human
tear fluid.
Please read this carton
carefully and keep for future
reference.
TAMPER EVIDENT: For your
protection, this bottle has an
imprinted seal around the neck.
Do not use if seal is damaged
or missing at time of purchase.
Alcon
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134 USA
Printed in USA
©2000, 2003, 2010 Alcon, Inc.
300047379-0321
LOT: EXP:

NDC 0065-0530-04
eye-
stream®
eye wash
solution
sterile
Alcon
4 FL OZ (118 mL)
EYE-STREAM® eye wash solution is
a sterile and stable solution that is
specially designed and packaged for
use in the eye(s). Formulated as a
buffered salt solution, it closely
approximates normal human tear fluid.
Please read this carton carefully
and keep for future reference.
TAMPER EVIDENT:
For your protection, this bottle has an
imprinted seal around the neck. Do not
use if seal is damaged or missing at
time of purchase.
Alcon
©
ALCON LABORATORIES, INC.
6201 South Freeway
Fort Worth, Texas 76134 USA
© 2000, 2003, 2009 Alcon, Inc.
9004563-0409
LOT:
EXP:

| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0065-0530-01 | ML - Milliliter | 0065-0530 | 1108ae72-0cf6-4cdb-aa4b-e1e6636007d6 | 1 | 2014-10-03 |
| 0065-0530-04 | ML - Milliliter | 0065-0530 | f64ca372-b3be-4eb4-9ca3-c9f16fd4206c | 1 | 2014-10-03 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Water | ACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Water | ACTIVE MOIETY | 059QF0KO0R | 1 | |
| Benzalkonium Chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | 1 | |
| Magnesium Chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| Potassium Chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| Sodium Acetate | INACTIVE INGREDIENT | 4550K0SC9B | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0065-0530 | 0065-0530-01, 0065-0530-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Water | 059QF0KO0R | ACTIB |
| Benzalkonium Chloride | F5UM2KM3W7 | IACT |
| Calcium Chloride | M4I0D6VV5M | IACT |
| Magnesium Chloride | 02F3473H9O | IACT |
| Potassium Chloride | 660YQ98I10 | IACT |
| Sodium Acetate | 4550K0SC9B | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Trisodium Citrate Dihydrate | B22547B95K | IACT |
| Sodium Hydroxide | 55X04QC32I | IACT |
| Hydrochloric Acid | QTT17582CB | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION / INTRAMUSCULAR | 4 %w/v | ||
| Trisodium Citrate Dihydrate | TRISODIUM CITRATE DIHYDRATE | B22547B95K | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / EXTRACORPOREAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / TOPICAL | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / DENTAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INTRACARDIAC | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAVITREAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACAUDAL | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET / ORAL | 10 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVENOUS | 78 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2922 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | OINTMENT / TOPICAL | 0.03 %w/w | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION / OPHTHALMIC | 1 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / DENTAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / NASAL | 20 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRABURSAL | ADJ PH | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INTRAVENOUS | 1 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / RETROBULBAR | ADJ PH | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION / INFILTRATION | 0.33 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAMUSCULAR | 176 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRA-ARTICULAR | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / ORAL | 148 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION / SUBCUTANEOUS | ADJ PH | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| Sodium Acetate | SODIUM ACETATE | 4550K0SC9B | INJECTION / INTRADERMAL | 1.6 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | GEL, METERED / TOPICAL | ADJ PH | ||
| Sodium Acetate | SODIUM ACETATE | 4550K0SC9B | SOLUTION / ORAL | 44 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INFILTRATION | 0.37 %w/v | ||
| Sodium Acetate | SODIUM ACETATE | 4550K0SC9B | INJECTION / INTRACAVITARY | 0.1 ml | ||
| Sodium Acetate | SODIUM ACETATE | 4550K0SC9B | SOLUTION / TOPICAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | LOTION / TOPICAL | 21 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRATUMOR | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRADERMAL | ADJ PH | ||
| Trisodium Citrate Dihydrate | TRISODIUM CITRATE DIHYDRATE | B22547B95K | SUSPENSION / RESPIRATORY (INHALATION) | 2 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | LIQUID / NASAL | ADJ PH | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAMUSCULAR | 306 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| Trisodium Citrate Dihydrate | TRISODIUM CITRATE DIHYDRATE | B22547B95K | SOLUTION / INTRAVENOUS | 41 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRA-ARTICULAR | ADJ PH | ||
| Sodium Acetate | SODIUM ACETATE | 4550K0SC9B | SOLUTION / INTRAOCULAR | 195 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRA-ARTICULAR | 1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE, EXTENDED RELEASE / ORAL | 41 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / RESPIRATORY (INHALATION) | 8 %w/v | ||
| Hydrochloric Acid | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / SUBCUTANEOUS | 1037 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / RETROBULBAR | ADJ PH |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ff11bbdb-5c23-4513-b514-68175d9efc0d | ff9560df-d834-57a8-37b0-3f10e82f5a5d | 2025-08-15 | Warnings | ff11bbdb-5c23-4513-b514-68175d9efc0d ff9560df-d834-57a8-37b0-3f10e82f5a5d |
Adverse event summaries are temporarily unavailable. Other product information remains available.